Halozyme Therapeutics (HALO) Interest Coverage Ratio (2011 - 2026)

Halozyme Therapeutics (HALO) has 15 years of Interest Coverage Ratio data on file, last reported at 33.5 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 7.1% year-over-year to 33.5 in Q1 2026; TTM through Mar 2026 was 84.61, a 156.51% increase from a year earlier, with the FY2025 full-year figure at 25.87, down 15.1% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 33.5, up from 11.09 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for HALO reached as high as 46.07 in Q2 2025 and fell as low as 6.0 in Q3 2025.
• Historically, Interest Coverage Ratio has averaged 24.17 across 5 years, with a median of 21.2 in 2024.
• Across the five-year window, Interest Coverage Ratio jumped 91.55% in 2023 and sank 83.36% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 16.3 in 2022, then soared by 67.08% to 27.24 in 2023, then jumped by 41.91% to 38.66 in 2024, then plunged by 71.31% to 11.09 in 2025, then jumped by 202.07% to 33.5 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 33.5 in Q1 2026, 11.09 in Q4 2025, and 6.0 in Q3 2025.